SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
426 MZ <<<MGI 114 is definitely lagging in clinical trials development>seminole-10/16/1997
425 David Thanks for the link. Joesph's questions were wonderful. Yesterday waseminole-10/16/1997
424 For me there was a sum total of one disappointment in the quarterly news releasDavid Cathcart-10/16/1997
423 <Drug related toxicity at the present level of 14.15 mg/m2 appears to only eDavid Cathcart-10/16/1997
422 <i> Drug related toxicity at the present level of 14.15 mg/m2 appears to Peter Silsbee-10/16/1997
421 Miljenko, When questioned about sales expectations for 4Q, which is typically David Cathcart-10/16/1997
420 David: Thanks. I am bit disappointed with 3Q Salagen sales, first Q sales/licMiljenko Zuanic-10/15/1997
419 Miljenko, I basically agree with your three points but I question what I saw aDavid Cathcart-10/15/1997
418 Peter: Glad that you asked this question. First let me say that, IMO, today nMiljenko Zuanic-10/15/1997
417 Rick Looks like Blitzer and I like scenario three. MGI PHARMA says outlook tiseminole-10/15/1997
416 Richard, Both DavidDavid Cathcart-10/15/1997
415 David Just something I ran across that may generate interest by the big money seminole-10/15/1997
414 Three questions for the thread: Does anyone have any comments on the appearancBiomaven-10/15/1997
413 Richard: I read your post and thought: gee, maybe I should be a little disciplDavid Cathcart-10/15/1997
412 Winston: As you know, there is no immediate need for cash, and Blitzer holds oscaram(o)uche-10/15/1997
411 Rick Good analysis. Looking forward this kind of analysis is very important fseminole-10/15/1997
410prnewswire.comscaram(o)uche-10/15/1997
409 Rick, Perhaps Blitzer is just keeping a poker face. If he appears anxious to debocaburgerman-10/15/1997
408 David, Whats the matter with being filthy? You've been pushing prettyDavid Graham-10/15/1997
407 Rick: Great post. However, I'm no longer totally in the "scene threeDavid Cathcart-10/15/1997
406 lrb: No ignorance. You're looking at it in a very constructive way. You&scaram(o)uche-10/15/1997
405 LRB What makes the MGI Pharma scenario different is that the "financiallyDavid Cathcart-10/15/1997
404 Seppi, What are you famous now, You can't answer the phone? EVEN TO David Graham-10/15/1997
403 Irb <<<How many MGI investors would be comfortable investing inseminole-10/15/1997
402 The feeling of most posters to this thread is that MOGN is currently undervaluelrb-10/15/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News